You talk to your broker. You meet with your CFO. You think you're the one calling the shots on your self-funded health plan. But there's someone else in the room, someone you've probably never met: the medical stop loss underwriter. They price risk. They also quietly shape your plan design, limit your drug coverage, affect your network choices, and even push you into programs you never wanted. Most employers have no idea this is happening until a claim gets denied or a renewal blindsides them.
The Deductible You Didn't Really Choose
Every self-funded employer believes they pick their specific stop loss deductible based on how much risk they can handle. In reality, the underwriter's risk appetite for your industry, location, and workforce demographics often leaves you with only one or two viable options, and those options come with strings attached.
Say an underwriter sees a history of high-cost cancer claims in your group. They may refuse to write a $50,000 specific deductible. Suddenly your only choice is $75,000 or $100,000, exposing your company to a bigger share of each claim. Or you can redesign your plan to reduce risk: narrowing networks, raising copays, or adding utilization management the underwriter demands. Their aversion becomes your plan's architecture.
Stop loss underwriting is a veto power, not a pricing exercise. You don't choose the deductible. The underwriter chooses what they'll allow you to have.
The Drug Exclusions Hiding in Plain Sight
Drug-specific exclusions are now common in stop loss contracts, and few benefits professionals talk about them. An underwriter might issue a policy endorsement that excludes coverage for a gene therapy like Zolgensma, priced around $2.1 million for a single dose, or a CAR-T cell therapy with list prices from $373,000 to $475,000, unless you prove you have a separate carve-out arrangement.
Your health plan may list the therapy as covered, but the stop loss policy won't reimburse you when a claim hits. Your company is left self-funding a seven-figure treatment or litigating the exclusion. Employees have no idea this invisible veto exists until someone in their family needs that drug.
Employers respond by layering on specialty drug stop loss, separate reinsurance, or narrow pharmacy networks, all to satisfy an underwriter's risk model.
The Data They See That You Don't
Underwriters see everything you don't. They aggregate claims data across dozens or hundreds of similar groups. They spot emerging trends: a spike in autoimmune disease among administrative staff in a certain region, or a cluster of bariatric claims in a specific ZIP code, long before any single employer can.
As the plan sponsor, you're entitled to your own claims data. What you often lack is the time, tooling, or TPA cooperation to turn it into benchmarks you can act on. The underwriter already holds that cross-market view.
This lets them attach conditions to your coverage. They can demand proof that your wellness program meets their threshold before offering a competitive rate. They can require you to use a specific high-cost case management vendor, even if your team already has a preferred partner. You comply not because the vendor is best for your employees, but because the underwriter's algorithm demands it.
Your health plan's operations are now driven by someone who never sees a patient.
Network Pressure You Never Noticed
Stop loss underwriters are also becoming de facto network regulators. If your group has a high out-of-network claim rate, or if your network lacks coverage for specialized centers like transplant hospitals or proton therapy facilities, the underwriter will either decline to quote or load your premium.
The result is a push into narrow, tiered networks that look a lot like HMOs, even if your company culture values employee choice. Where employees can find a doctor is shaped not by your benefits philosophy, but by an actuarial spreadsheet in an underwriter's office.
Why Stop Loss Sits Outside Health Insurance Rules
Stop loss carriers can impose all of this because, in most states, stop loss coverage is not regulated as health insurance. It protects the employer's balance sheet rather than the member's care, so it sits outside many of the ACA rules that bind the underlying plan. Self-funded plans are exempt from the ACA's essential health benefit requirements and rating restrictions, and state and federal limits on exclusions often do not apply to stop loss coverage. That is the mechanism behind the drug endorsements and behavioral clauses above: the plan still has to cover the member, while the carrier backstopping the employer can carve out the risk.
Some states have pushed back at the small-group level, setting minimum attachment points so a small employer's plan retains enough real risk to stay genuinely self-funded. For mid-size and large groups, the underwriter's terms carry most of the weight. Read the contract the way an underwriter does.
What You Can Actually Do About It
Stop loss is a strategic negotiation about what your plan can and cannot do, not a commodity renewal.
Next time you receive a stop loss quote, don't just glance at the premium and deductible. Ask your broker for a full review of:
- Any drug-specific endorsements or exclusions
- Data requirements the underwriter used to price your group
- Network utilization thresholds that influenced the quote
- Any behavioral requirements, like wellness program requirements or case management vendor mandates
If your broker says "that's just standard," push harder. Nothing is standard in today's stop loss market.
Your Next Move
Request a written underwriting rationale from your carrier. Few will provide it, but those that do hand you the blueprint for negotiating better terms and greater plan flexibility next year.
The stop loss underwriter is a silent architect of your employee benefits. Know who's really designing your plan.